Cervical Traction Collars Global Market Report 2025

The increasing prevalence of neck-related disorders is anticipated to drive the growth of the cervical traction collars market in the coming years. Neck-related disorders refer to conditions affecting the cervical spine, including muscles, ligaments, nerves, vertebrae, and intervertebral discs. The rise in these disorders is largely due to extended screen time, which promotes poor posture and causes prolonged strain on the neck muscles and spine. Cervical traction collars provide relief by gently stretching the cervical spine, reducing pressure on compressed discs and pinched nerves, improving blood circulation, promoting proper alignment, and relieving muscle tension. This makes them an effective non-invasive solution for managing chronic neck pain and stiffness. For example, according to the National Library of Medicine in February 2024, it is projected that by 2050, there will be 269 million cases of neck discomfort worldwide, a 32.5% increase from 2020. This rising prevalence of neck-related disorders is driving the cervical traction collars market.

Companies in the microneedle flu vaccine market are increasingly forming strategic collaborations to develop next-generation vaccine technologies. These partnerships aim to improve accessibility, stability, and rapid deployment in response to global health challenges. Strategic alliances involve organizations combining their strengths to achieve mutual long-term goals, often through resource sharing, joint development, or market expansion. For instance, in January 2025, BioNet, a Thailand-based vaccine manufacturer, was named a Concept Stage winner of the United States Biomedical Advanced Research and Development Authority (BARDA) Patch Forward Prize in collaboration with LTS Lohmann Therapie-Systeme AG, a Germany-based developer of drug delivery systems. This collaboration merges BioNet’s proprietary mRNA vaccine technology with LTS’s dissolvable microneedle patch system, creating a new platform that enhances vaccine stability, simplifies distribution, and facilitates self-administration. This initiative is a significant step toward transforming global vaccine accessibility, allowing rapid manufacturing and eliminating reliance on cold-chain logistics.

In May 2024, Thuasne Group, a France-based medical device manufacturer, acquired Corflex Inc. for an undisclosed amount. This acquisition is part of Thuasne’s strategy to expand its global product portfolio, particularly in the orthopedic and medical device sectors, and strengthen its presence in the U.S. market. By doing so, Thuasne aims to position itself for greater growth and enhanced competitiveness within the healthcare industry. Corflex Inc., based in the U.S., produces a range of rigid cervical collars, including tracheotomy models, and cervical traction collars used for spinal support and rehabilitation.

Major players in the cervical traction collars market are Enovis Corporation, Compass Health, DeRoyal Industries Inc., Breg Inc., Trulife Limited, Dynamic Techno Medicals Pvt. Ltd., Orthomerica Products Inc., Bauerfeind AG, Jiangsu Folee Medical Equipment Co. Ltd., Aspen Medical Products LLC, Advanced Orthopaedics Inc., Disc Disease Solutions Inc., Pettibon System Inc., Saunders Group, Posture Pro Inc., Thuasne Group, Meditrac Ltd., Orthoservice AG, Everyway Medical Instruments Co. Ltd., Scoliolife.

North America was the largest region in the cervical traction collars market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cervical traction collars report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cervical traction collars market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cervical traction collars market consists of sales of posture corrective collars, and electronic cervical traction devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.